Makoto Naganuma

Kansai Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Shigeru Sakamoto

Osaka University Hospital

JAPAN

View details

Noriyo YAMASHIKI

Associate Professor

Kansai Medical University

JAPAN

View details

Mamoru Watanabe

JAPAN

View details

Mitsuhiro Takeno

Nippon Medical School Musashi Kosugi Hospital

JAPAN

View details

Hironao Matsumoto

Kansai Medical University

JAPAN

View details

Tomohisa Sujino

Keio University School of Medicine

JAPAN

View details

Masaaki Shimatani

Kansai Medical University

JAPAN

View details

Kenji Watanabe

University of Toyama

JAPAN

View details

Philippe Pinton

Senior Vice President, Global Head

Ferring Pharmaceuticals (Denmark)

DENMARK

View details

Eiji ARAMAKI

Professor

Nara Institute of Science and Technology（NAIST）

JAPAN

View details

Akihiko Oka

Lecturer

Shimane University Faculty of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Makoto Naganuma

Research Interests

Explore related searches

Contact this professor

Articles (23)

Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet’s Disease from Immunological and Clinical Perspectives

Non-injection resection using bipolar soft coagulation mode for large colorectal polyps including incidental cancer

Antitumor Necrosis Factor-Refractory Esophageal Lesions in Crohn's Disease Successfully Treated With Upadacitinib

Clinical Outcomes for Patients With Ulcerative Colitis in Cases of Withdrawal and Resumption of Janus Kinase Inhibitors: Multicenter Cohort Study

First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study

Reply to “Severe ulcerative colitis: diagnostic criteria and therapy”

Successful pancreatic pseudocyst drainage using lumen-apposing metal stent for preventing re-rupture of splenic artery pseudoaneurysm

Impact of twice‐daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis

Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”

Effective hemostasis under gel immersion endoscopy using inflated balloons on the tip of double balloon endoscope for active bleeding in the small intestine

Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

Narrowing the Patient–Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App

Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis

Evaluation of a new method, “non-injection resection using bipolar soft coagulation mode (NIRBS)”, for colonic adenomatous lesions

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis

Reply

Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine

Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis

Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial

Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis

Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials

Collaborators (11)

Shigeru Sakamoto

Noriyo YAMASHIKI

Mamoru Watanabe

Mitsuhiro Takeno

Hironao Matsumoto

Tomohisa Sujino

Masaaki Shimatani

Kenji Watanabe

Philippe Pinton

Eiji ARAMAKI

Akihiko Oka

Make your next move.